Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Air Pollutants | 33 | 2011 | 2931 | 2.010 |
Why?
|
Particulate Matter | 27 | 2011 | 2635 | 1.830 |
Why?
|
Germany | 39 | 2012 | 882 | 1.210 |
Why?
|
Environmental Monitoring | 17 | 2011 | 1468 | 1.160 |
Why?
|
Air Pollution | 15 | 2011 | 2391 | 1.100 |
Why?
|
Particle Size | 30 | 2011 | 1634 | 1.090 |
Why?
|
Fibrinogen | 9 | 2011 | 893 | 1.050 |
Why?
|
Inhalation Exposure | 9 | 2011 | 432 | 0.930 |
Why?
|
Myocardial Infarction | 24 | 2011 | 11513 | 0.840 |
Why?
|
Urban Health | 6 | 2011 | 532 | 0.730 |
Why?
|
Vehicle Emissions | 6 | 2011 | 651 | 0.650 |
Why?
|
Respiratory Tract Diseases | 6 | 2011 | 744 | 0.640 |
Why?
|
C-Reactive Protein | 13 | 2010 | 3853 | 0.630 |
Why?
|
Environmental Exposure | 13 | 2011 | 4554 | 0.560 |
Why?
|
Mortality | 6 | 2011 | 2910 | 0.520 |
Why?
|
Polymorphism, Single Nucleotide | 30 | 2012 | 16044 | 0.510 |
Why?
|
Heart Rate | 9 | 2011 | 4207 | 0.500 |
Why?
|
Interleukin-6 | 7 | 2010 | 3227 | 0.470 |
Why?
|
Arrhythmias, Cardiac | 4 | 2012 | 2258 | 0.390 |
Why?
|
Survivors | 6 | 2010 | 2379 | 0.360 |
Why?
|
Myocardial Ischemia | 5 | 2011 | 2132 | 0.350 |
Why?
|
Seasons | 10 | 2011 | 1521 | 0.340 |
Why?
|
Cardiovascular Diseases | 15 | 2012 | 15657 | 0.340 |
Why?
|
Coronary Disease | 7 | 2012 | 5915 | 0.330 |
Why?
|
Soot | 1 | 2011 | 219 | 0.330 |
Why?
|
Weather | 4 | 2011 | 234 | 0.330 |
Why?
|
Temperature | 7 | 2011 | 2233 | 0.320 |
Why?
|
Genome-Wide Association Study | 23 | 2012 | 12806 | 0.310 |
Why?
|
Heart Conduction System | 2 | 2012 | 1007 | 0.310 |
Why?
|
Regression Analysis | 13 | 2011 | 6329 | 0.290 |
Why?
|
Cities | 6 | 2011 | 542 | 0.290 |
Why?
|
von Willebrand Factor | 3 | 2010 | 680 | 0.290 |
Why?
|
Aged | 74 | 2012 | 171343 | 0.270 |
Why?
|
Long QT Syndrome | 2 | 2011 | 473 | 0.270 |
Why?
|
Disease | 1 | 2011 | 675 | 0.260 |
Why?
|
Leukocyte Count | 1 | 2010 | 1606 | 0.250 |
Why?
|
Physical Exertion | 1 | 2008 | 667 | 0.250 |
Why?
|
Electrocardiography | 10 | 2012 | 6408 | 0.240 |
Why?
|
Aerosols | 5 | 2011 | 634 | 0.240 |
Why?
|
Poisson Distribution | 5 | 2011 | 507 | 0.230 |
Why?
|
Haplotypes | 10 | 2012 | 2727 | 0.230 |
Why?
|
Tachycardia, Supraventricular | 1 | 2006 | 272 | 0.220 |
Why?
|
Middle Aged | 73 | 2012 | 223257 | 0.220 |
Why?
|
Coronary Artery Disease | 5 | 2011 | 6558 | 0.220 |
Why?
|
Blood Coagulation | 4 | 2011 | 1163 | 0.210 |
Why?
|
Dyspnea | 1 | 2011 | 1352 | 0.210 |
Why?
|
Carbon Monoxide | 5 | 2010 | 560 | 0.210 |
Why?
|
Motor Vehicles | 1 | 2004 | 280 | 0.200 |
Why?
|
Public Health | 4 | 2011 | 2681 | 0.200 |
Why?
|
Heart Diseases | 5 | 2011 | 2817 | 0.200 |
Why?
|
Nitrogen Dioxide | 6 | 2011 | 541 | 0.200 |
Why?
|
Hazardous Substances | 1 | 2002 | 153 | 0.190 |
Why?
|
Respiration Disorders | 1 | 2005 | 364 | 0.190 |
Why?
|
Male | 78 | 2012 | 364142 | 0.190 |
Why?
|
Cross-Over Studies | 4 | 2011 | 2108 | 0.180 |
Why?
|
Humans | 110 | 2012 | 766766 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2012 | 12245 | 0.170 |
Why?
|
Risk Assessment | 14 | 2011 | 24295 | 0.170 |
Why?
|
Multigene Family | 4 | 2011 | 1081 | 0.170 |
Why?
|
Nanoparticles | 1 | 2011 | 1966 | 0.160 |
Why?
|
Thromboplastin | 2 | 2011 | 289 | 0.160 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2011 | 127 | 0.160 |
Why?
|
Meteorological Concepts | 2 | 2009 | 30 | 0.150 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 3246 | 0.150 |
Why?
|
Genetic Loci | 4 | 2011 | 2630 | 0.150 |
Why?
|
Tachycardia, Ventricular | 1 | 2006 | 1313 | 0.140 |
Why?
|
Genotype | 11 | 2012 | 13036 | 0.140 |
Why?
|
Prediabetic State | 3 | 2012 | 547 | 0.140 |
Why?
|
Chromosome Mapping | 5 | 2012 | 4619 | 0.140 |
Why?
|
Female | 68 | 2012 | 396520 | 0.140 |
Why?
|
Adult | 48 | 2012 | 223307 | 0.140 |
Why?
|
Sulfur Dioxide | 4 | 2011 | 178 | 0.130 |
Why?
|
Interleukin-1 | 2 | 2010 | 1251 | 0.130 |
Why?
|
Dust | 2 | 2010 | 490 | 0.120 |
Why?
|
Epidemiologic Studies | 3 | 2011 | 677 | 0.120 |
Why?
|
Gene Frequency | 6 | 2012 | 3624 | 0.120 |
Why?
|
Risk Factors | 25 | 2012 | 74881 | 0.110 |
Why?
|
Metabolome | 2 | 2011 | 1009 | 0.110 |
Why?
|
Time Factors | 11 | 2011 | 40149 | 0.110 |
Why?
|
Longitudinal Studies | 9 | 2011 | 14762 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2011 | 640 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2011 | 1241 | 0.110 |
Why?
|
Comorbidity | 7 | 2012 | 10580 | 0.110 |
Why?
|
Sickness Impact Profile | 2 | 2011 | 299 | 0.110 |
Why?
|
Inflammation | 7 | 2011 | 10860 | 0.110 |
Why?
|
China | 4 | 2011 | 2383 | 0.110 |
Why?
|
Aged, 80 and over | 21 | 2012 | 59550 | 0.110 |
Why?
|
Europe | 6 | 2009 | 3430 | 0.100 |
Why?
|
Leisure Activities | 2 | 2011 | 310 | 0.100 |
Why?
|
Quantitative Trait Loci | 2 | 2012 | 2136 | 0.100 |
Why?
|
Case-Control Studies | 10 | 2012 | 22248 | 0.100 |
Why?
|
Eukaryotic Initiation Factor-4G | 1 | 2012 | 68 | 0.100 |
Why?
|
Death Certificates | 2 | 2010 | 172 | 0.100 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2010 | 299 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2011 | 426 | 0.090 |
Why?
|
Fasting | 3 | 2012 | 1609 | 0.090 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2011 | 582 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 11 | 2012 | 18075 | 0.090 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2011 | 141 | 0.090 |
Why?
|
Logistic Models | 5 | 2011 | 13278 | 0.090 |
Why?
|
Motor Activity | 2 | 2011 | 2711 | 0.090 |
Why?
|
Cohort Studies | 18 | 2012 | 41710 | 0.090 |
Why?
|
Triterpenes | 1 | 2011 | 78 | 0.090 |
Why?
|
Atmosphere | 1 | 2010 | 32 | 0.090 |
Why?
|
Overweight | 2 | 2012 | 2446 | 0.090 |
Why?
|
Torsades de Pointes | 1 | 2011 | 78 | 0.090 |
Why?
|
Serum Amyloid A Protein | 1 | 2010 | 128 | 0.090 |
Why?
|
Factor V | 1 | 2011 | 168 | 0.090 |
Why?
|
Blood Chemical Analysis | 1 | 2012 | 434 | 0.090 |
Why?
|
Exercise Test | 3 | 2008 | 2188 | 0.090 |
Why?
|
Cause of Death | 2 | 2011 | 3716 | 0.090 |
Why?
|
Lung Diseases | 2 | 2011 | 1941 | 0.090 |
Why?
|
Serum | 1 | 2011 | 206 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14652 | 0.090 |
Why?
|
Geography | 2 | 2011 | 651 | 0.080 |
Why?
|
Odds Ratio | 4 | 2012 | 9661 | 0.080 |
Why?
|
Atrial Natriuretic Factor | 1 | 2011 | 350 | 0.080 |
Why?
|
Factor VII | 1 | 2010 | 139 | 0.080 |
Why?
|
Oxidants, Photochemical | 1 | 2010 | 77 | 0.080 |
Why?
|
Blood Pressure | 4 | 2011 | 8533 | 0.080 |
Why?
|
Climate | 1 | 2010 | 146 | 0.080 |
Why?
|
Chloride Channels | 1 | 2011 | 221 | 0.080 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2011 | 276 | 0.080 |
Why?
|
Duffy Blood-Group System | 1 | 2009 | 61 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2010 | 412 | 0.080 |
Why?
|
Promoter Regions, Genetic | 3 | 2009 | 5789 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 378 | 0.080 |
Why?
|
Sex Characteristics | 2 | 2011 | 2645 | 0.080 |
Why?
|
Genetic Variation | 5 | 2012 | 6612 | 0.080 |
Why?
|
Blood Glucose | 3 | 2012 | 6422 | 0.080 |
Why?
|
Arm | 1 | 2012 | 591 | 0.080 |
Why?
|
Epidemiology | 1 | 2011 | 278 | 0.080 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11920 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2010 | 1131 | 0.080 |
Why?
|
Prospective Studies | 11 | 2012 | 54871 | 0.080 |
Why?
|
Menarche | 1 | 2011 | 532 | 0.080 |
Why?
|
Amidohydrolases | 1 | 2009 | 160 | 0.080 |
Why?
|
Vesicular Transport Proteins | 1 | 2011 | 376 | 0.080 |
Why?
|
Polymorphism, Genetic | 2 | 2009 | 4249 | 0.080 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2008 | 84 | 0.080 |
Why?
|
Wind | 1 | 2008 | 44 | 0.080 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 642 | 0.070 |
Why?
|
Peroxidase | 1 | 2011 | 610 | 0.070 |
Why?
|
Plasma | 1 | 2011 | 583 | 0.070 |
Why?
|
Sphingolipids | 1 | 2009 | 177 | 0.070 |
Why?
|
Hypertension | 5 | 2012 | 8616 | 0.070 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2009 | 322 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 800 | 0.070 |
Why?
|
Factor VIII | 1 | 2010 | 349 | 0.070 |
Why?
|
Lymphocyte Count | 1 | 2010 | 794 | 0.070 |
Why?
|
Parkinson Disease | 2 | 2012 | 2884 | 0.070 |
Why?
|
Body Mass Index | 8 | 2012 | 13050 | 0.070 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2011 | 772 | 0.070 |
Why?
|
P-Selectin | 1 | 2010 | 598 | 0.070 |
Why?
|
ABO Blood-Group System | 1 | 2010 | 381 | 0.070 |
Why?
|
Cold Temperature | 1 | 2011 | 794 | 0.070 |
Why?
|
Chemokine CCL2 | 1 | 2009 | 604 | 0.070 |
Why?
|
Homozygote | 2 | 2009 | 1775 | 0.070 |
Why?
|
Periodicity | 1 | 2008 | 347 | 0.070 |
Why?
|
Lipoproteins | 1 | 2011 | 871 | 0.070 |
Why?
|
Registries | 5 | 2011 | 8351 | 0.070 |
Why?
|
Chromosomes, Human | 1 | 2008 | 437 | 0.070 |
Why?
|
Environmental Health | 1 | 2009 | 297 | 0.070 |
Why?
|
Nitrous Oxide | 1 | 2006 | 166 | 0.060 |
Why?
|
Corneal Diseases | 1 | 2011 | 535 | 0.060 |
Why?
|
Metabolomics | 2 | 2012 | 1675 | 0.060 |
Why?
|
Quality Control | 1 | 2008 | 834 | 0.060 |
Why?
|
Oxidative Stress | 3 | 2011 | 3139 | 0.060 |
Why?
|
Cataract | 1 | 2011 | 837 | 0.060 |
Why?
|
Retinal Diseases | 1 | 2011 | 709 | 0.060 |
Why?
|
Rest | 1 | 2010 | 940 | 0.060 |
Why?
|
Carbon | 2 | 2008 | 673 | 0.060 |
Why?
|
American Heart Association | 1 | 2010 | 1049 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1250 | 0.060 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 1691 | 0.060 |
Why?
|
Phenotype | 6 | 2012 | 16724 | 0.060 |
Why?
|
Spectrum Analysis | 1 | 2006 | 443 | 0.060 |
Why?
|
Hot Temperature | 1 | 2011 | 1442 | 0.060 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1479 | 0.060 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4424 | 0.060 |
Why?
|
Genetic Markers | 4 | 2012 | 2603 | 0.060 |
Why?
|
DNA | 2 | 2008 | 7208 | 0.060 |
Why?
|
Netherlands | 3 | 2005 | 2277 | 0.060 |
Why?
|
Glucose Tolerance Test | 3 | 2012 | 1180 | 0.060 |
Why?
|
Body Height | 1 | 2010 | 1562 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1101 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 1 | 2010 | 828 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1567 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1555 | 0.060 |
Why?
|
Rabbits | 1 | 2010 | 4752 | 0.050 |
Why?
|
Linear Models | 2 | 2011 | 5874 | 0.050 |
Why?
|
Time | 1 | 2004 | 550 | 0.050 |
Why?
|
Body Composition | 1 | 2012 | 2441 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2921 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2010 | 1422 | 0.050 |
Why?
|
Cost of Illness | 1 | 2012 | 1949 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1750 | 0.050 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2005 | 270 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2590 | 0.050 |
Why?
|
Homeostasis | 2 | 2010 | 3342 | 0.050 |
Why?
|
Atrial Fibrillation | 2 | 2010 | 5182 | 0.050 |
Why?
|
Glaucoma | 1 | 2011 | 1194 | 0.050 |
Why?
|
Inflammation Mediators | 2 | 2009 | 1889 | 0.050 |
Why?
|
Quality of Life | 3 | 2012 | 13476 | 0.050 |
Why?
|
Lung | 3 | 2011 | 10067 | 0.050 |
Why?
|
Blood Platelets | 2 | 2010 | 2465 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2030 | 0.050 |
Why?
|
Myocardium | 2 | 2011 | 4765 | 0.050 |
Why?
|
Monocytes | 1 | 2010 | 2600 | 0.050 |
Why?
|
Nitric Oxide | 2 | 2008 | 2141 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2008 | 1276 | 0.050 |
Why?
|
Sex Factors | 4 | 2011 | 10619 | 0.050 |
Why?
|
Population | 2 | 2012 | 140 | 0.050 |
Why?
|
Models, Genetic | 4 | 2012 | 3450 | 0.050 |
Why?
|
Urban Population | 1 | 2009 | 2040 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2815 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2005 | 707 | 0.040 |
Why?
|
Heart | 2 | 2010 | 4425 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2012 | 3314 | 0.040 |
Why?
|
Activities of Daily Living | 2 | 2010 | 2429 | 0.040 |
Why?
|
Genome, Human | 2 | 2010 | 4443 | 0.040 |
Why?
|
Social Class | 1 | 2009 | 2007 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4626 | 0.040 |
Why?
|
Models, Statistical | 3 | 2009 | 5091 | 0.040 |
Why?
|
Life Style | 1 | 2011 | 3926 | 0.040 |
Why?
|
Age Factors | 4 | 2012 | 18397 | 0.040 |
Why?
|
Finland | 3 | 2005 | 608 | 0.040 |
Why?
|
Health Care Costs | 1 | 2011 | 3242 | 0.040 |
Why?
|
Pedigree | 3 | 2011 | 4539 | 0.040 |
Why?
|
Models, Biological | 3 | 2012 | 9461 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3270 | 0.040 |
Why?
|
Glucose | 1 | 2009 | 4340 | 0.040 |
Why?
|
Markov Chains | 2 | 2011 | 974 | 0.040 |
Why?
|
Diabetes Mellitus | 3 | 2012 | 5887 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2004 | 1791 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3804 | 0.030 |
Why?
|
Likelihood Functions | 2 | 2011 | 993 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9357 | 0.030 |
Why?
|
Smoking | 2 | 2010 | 9077 | 0.030 |
Why?
|
Mental Health | 1 | 2010 | 3270 | 0.030 |
Why?
|
Life Expectancy | 1 | 2002 | 1249 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2012 | 20144 | 0.030 |
Why?
|
Self Report | 3 | 2011 | 3771 | 0.030 |
Why?
|
Humidity | 2 | 2009 | 206 | 0.030 |
Why?
|
Meta-Analysis as Topic | 2 | 2010 | 1365 | 0.030 |
Why?
|
Alleles | 3 | 2011 | 6895 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3420 | 0.030 |
Why?
|
Obesity | 3 | 2012 | 13090 | 0.030 |
Why?
|
Hospitalization | 2 | 2011 | 10823 | 0.030 |
Why?
|
Exercise | 1 | 2010 | 5945 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5368 | 0.030 |
Why?
|
Health Status Indicators | 2 | 2009 | 968 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2008 | 7841 | 0.030 |
Why?
|
Ozone | 2 | 2008 | 500 | 0.030 |
Why?
|
Animals | 6 | 2012 | 168930 | 0.020 |
Why?
|
trans-Golgi Network | 1 | 2011 | 33 | 0.020 |
Why?
|
Erythrocytes | 2 | 2012 | 2412 | 0.020 |
Why?
|
Patient Readmission | 1 | 2005 | 3283 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2012 | 655 | 0.020 |
Why?
|
Aging | 1 | 2010 | 8731 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2011 | 290 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2010 | 187 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2010 | 91 | 0.020 |
Why?
|
Health Surveys | 2 | 2012 | 4055 | 0.020 |
Why?
|
Population Groups | 1 | 2011 | 209 | 0.020 |
Why?
|
Base Pairing | 1 | 2010 | 139 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2012 | 39309 | 0.020 |
Why?
|
Carnitine | 1 | 2011 | 253 | 0.020 |
Why?
|
Cross-Sectional Studies | 4 | 2012 | 26310 | 0.020 |
Why?
|
Injections, Spinal | 1 | 2010 | 317 | 0.020 |
Why?
|
Prevalence | 3 | 2012 | 15835 | 0.020 |
Why?
|
Work | 1 | 2010 | 195 | 0.020 |
Why?
|
Interleukin-1alpha | 1 | 2009 | 88 | 0.020 |
Why?
|
Young Adult | 6 | 2011 | 59939 | 0.020 |
Why?
|
Air | 1 | 2009 | 182 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2010 | 565 | 0.020 |
Why?
|
Data Collection | 2 | 2011 | 3321 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2009 | 260 | 0.020 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2010 | 239 | 0.020 |
Why?
|
Endosomes | 1 | 2011 | 521 | 0.020 |
Why?
|
Risk | 2 | 2010 | 9602 | 0.020 |
Why?
|
Diabetic Neuropathies | 1 | 2012 | 409 | 0.020 |
Why?
|
Thrombin | 1 | 2011 | 600 | 0.020 |
Why?
|
Vital Capacity | 1 | 2011 | 995 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2011 | 592 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2009 | 175 | 0.020 |
Why?
|
Glycine | 1 | 2011 | 670 | 0.020 |
Why?
|
Spirometry | 1 | 2011 | 929 | 0.020 |
Why?
|
North Carolina | 1 | 2008 | 329 | 0.020 |
Why?
|
Body Size | 1 | 2010 | 461 | 0.020 |
Why?
|
Health Status | 2 | 2011 | 4087 | 0.020 |
Why?
|
Soil | 1 | 2008 | 119 | 0.020 |
Why?
|
Office Visits | 1 | 2011 | 593 | 0.020 |
Why?
|
Fluorescence | 1 | 2010 | 751 | 0.020 |
Why?
|
Potassium | 1 | 2011 | 1314 | 0.020 |
Why?
|
Anthropometry | 1 | 2012 | 1336 | 0.020 |
Why?
|
Hemostasis | 1 | 2010 | 467 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 960 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2011 | 646 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1742 | 0.020 |
Why?
|
Sulfates | 1 | 2008 | 380 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1638 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2012 | 2342 | 0.020 |
Why?
|
Cell Size | 1 | 2008 | 625 | 0.020 |
Why?
|
Genetics, Population | 1 | 2011 | 943 | 0.020 |
Why?
|
Protein Precursors | 1 | 2011 | 1134 | 0.020 |
Why?
|
Blood Proteins | 1 | 2012 | 1194 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2011 | 12534 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2007 | 211 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2392 | 0.020 |
Why?
|
Waist Circumference | 1 | 2010 | 934 | 0.020 |
Why?
|
Eye Diseases | 1 | 2012 | 660 | 0.020 |
Why?
|
Hormones | 1 | 2010 | 866 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1828 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1250 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2869 | 0.020 |
Why?
|
Drug Utilization | 1 | 2011 | 1187 | 0.020 |
Why?
|
Thrombosis | 2 | 2010 | 2953 | 0.020 |
Why?
|
History, 18th Century | 1 | 2005 | 206 | 0.020 |
Why?
|
Amino Acids | 1 | 2011 | 1711 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3432 | 0.020 |
Why?
|
Neoplasms | 2 | 2011 | 22350 | 0.010 |
Why?
|
International Normalized Ratio | 1 | 2006 | 382 | 0.010 |
Why?
|
E-Selectin | 1 | 2006 | 575 | 0.010 |
Why?
|
Employment | 1 | 2010 | 1110 | 0.010 |
Why?
|
Macrophages | 2 | 2009 | 5783 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3342 | 0.010 |
Why?
|
Educational Status | 1 | 2011 | 2510 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4913 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1996 | 0.010 |
Why?
|
ras Proteins | 1 | 2009 | 1055 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2009 | 1026 | 0.010 |
Why?
|
Protein Conformation | 1 | 2011 | 3947 | 0.010 |
Why?
|
Drug Costs | 1 | 2011 | 1195 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1895 | 0.010 |
Why?
|
United States Environmental Protection Agency | 1 | 2003 | 139 | 0.010 |
Why?
|
United States | 3 | 2010 | 72951 | 0.010 |
Why?
|
Longevity | 1 | 2010 | 1083 | 0.010 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 899 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6020 | 0.010 |
Why?
|
Heterozygote | 1 | 2008 | 2795 | 0.010 |
Why?
|
Cardiovascular System | 1 | 2009 | 839 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3681 | 0.010 |
Why?
|
Angina Pectoris | 1 | 2005 | 956 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4142 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2142 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2011 | 2779 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3319 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4032 | 0.010 |
Why?
|
Social Support | 1 | 2010 | 2191 | 0.010 |
Why?
|
Population Surveillance | 1 | 2010 | 2594 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17608 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3692 | 0.010 |
Why?
|
Research Support as Topic | 1 | 2003 | 697 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4349 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2693 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 88904 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2009 | 2143 | 0.010 |
Why?
|
Neutrophils | 1 | 2010 | 3782 | 0.010 |
Why?
|
Software | 1 | 2012 | 4466 | 0.010 |
Why?
|
Genetic Testing | 1 | 2011 | 3591 | 0.010 |
Why?
|
Insulin | 1 | 2012 | 6608 | 0.010 |
Why?
|
Proteins | 1 | 2012 | 6002 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2010 | 3989 | 0.010 |
Why?
|
Biomedical Research | 1 | 2011 | 3459 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6207 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15416 | 0.010 |
Why?
|
Research | 1 | 2003 | 1977 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23717 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15908 | 0.010 |
Why?
|
Databases, Factual | 1 | 2008 | 8066 | 0.010 |
Why?
|
Mental Disorders | 1 | 2012 | 6869 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10745 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 7871 | 0.010 |
Why?
|
Stroke | 1 | 2012 | 9741 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 30213 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81889 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 65273 | 0.000 |
Why?
|